Trailing-twelve-month (TTM) revenue is $2.57 Billion with a year-over-year growth of +9.33%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $617,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $641,100,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-13 |
| Q1 FY2026Period ended 2026-03-31 | $644,800,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-30 | $663,200,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $2,566,500,000 |
Current P/S: $7,366,164,802 market capitalization ÷ $2,566,500,000 TTM revenue = 2.87x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:45:07.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $663.20M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:47:28.847Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asset-Based | $224M | $265M | $269M | $280M | $333M | $343M |
| Licensed-Based | $935M | $1.1B | $1.3B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia | N/A | N/A | N/A | N/A | N/A | $48M |
| AUSTRALIA | N/A | N/A |
$2.57B
$2.57 Billion
+9.33%
vs. $2.35B a year ago (TTM)
+10.67%
5 Year compound annual growth rate
1 Year
+9.33%
3 Year
+10.01%
5 Year
+10.67%
10 Year
+12.55%
15 Year
+10.13%
20 Year
+12.04%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $2.45B | +$170.40M | +7.49% |
| 2024 | $2.28B | +$236.50M | +11.60% |
| 2023 | $2.04B | +$168.00M | +8.98% |
| 2022 | $1.87B | +$171.30M | +10.08% |
| 2021 | $1.70B | +$309.80M | +22.30% |
| 2020 |
TTM Growth
+9.33%
3-Year CAGR
+10.01%
5-Year CAGR
+10.67%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $1.6B |
| $1.7B |
| Transaction-Based | $231M | $303M | $270M | $242M | $317M | $383M |
|---|
| N/A |
| N/A |
| $65M |
| CANADA | N/A | N/A | N/A | N/A | N/A | $155M |
|---|
| Europe excluding the United Kingdom | N/A | N/A | N/A | N/A | N/A | $220M |
|---|
| Non United States | $419M | $515M | $517M | $568M | $636M | $691M |
|---|
| Segment, Geographical, Group of Other Countries | N/A | N/A | N/A | N/A | N/A | $13M |
|---|
| UNITED STATES | $971M | $1.2B | $1.4B | $1.5B | $1.6B | $1.8B |
|---|
| $1.39B |
| +$210.50M |
| +17.85% |
| 2019 | $1.18B | +$159.10M | +15.60% |
| 2018 | $1.02B | +$108.20M | +11.87% |
| 2017 | $911.70M | +$113.10M | +14.16% |
| 2016 | $798.60M | +$9.80M | +1.24% |
